fda
FDA Withdraws Draft Guidance on CBD Enforcement Policy
After the Biden administration released a memo on Jan. 20 to all federal agencies informing them of a “regulatory freeze pending review,” the U.S. Food and Drug Administration (FDA) withdrew its “Cannabidiol Enforcement Policy; Draft Guidance for Industry.” Before it was withdrawn, the guidance was at the Office of Management and Budget (OMB) awaiting review. In ...
New Hampshire Becomes Latest State to Propose CBD Regs to Fill FDA Vacuum
As the U.S. Food and Drug Administration (FDA) continues to defy mounting requests from the U.S. Congress and the natural products industry to provide science-based and public health regulations for CBD, more states are rushing in to fill the vacuum. New Hampshire recently became the latest state to propose new state regulations for consumable hemp and CBD products. Kyle Turk, director for government affairs, ...
CRN: New FDA Announcement on CBD Signals Continued Agency Inaction
In response to a notice issued on Jan. 8, 2021, from the U.S. Food and Drug Administration (FDA), titled, “Better Data for a Better Understanding of the Use and Safety Profile of Cannabidiol (CBD) Products,” the Council for Responsible Nutrition (CRN) issued the following statement: “Today’s notice, late in the day, late in a week that ...
CRN Announces New, Upgraded Supplement OWL Platform
The Council for Responsible Nutrition (CRN) has announced upgrades to the Supplement OWL (Online Wellness Library), the dietary supplement industry’s self-regulatory product listing. Companies looking to participate in the Supplement OWL now have additional support options to upload their dietary supplement product information into this important industry initiative. “Serving as a resource for regulators, retailers, industry and consumers since ...
CHPA Responds to AMA Policy Calling For Increased Regulation of Dietary Supplements
At the Special Meeting of the American Medical Association (AMA) House of Delegates, physicians adopted new policy, which expands upon the AMA’s existing policy to call for more stringent federal regulation of dietary supplements—including increased oversight of manufacturing, marketing, product labeling and adverse event reporting. Under the new policy, the AMA strongly urges Congress to ...
Oleandrin Not to be Used as a Dietary Supplement Says FDA
On Sept. 4, the U.S. Food and Drug Administration (FDA) rejected an application to market Oleandrin as a dietary supplement, weeks after MyPillow CEO Mike Lindell promoted the extract as a potential treatment for the coronavirus to President Donald Trump and White House officials, according to Forbes. The FDA concluded that Oleandrin cannot legally be considered ...
New Hampshire Joins List of States to Propose CBD Regs
As the U.S. Food and Drug Administration (FDA) continues to defy mounting requests from the U.S. Congress and the natural products industry to provide science-based and public health regulations for CBD, more states are rushing in to fill the vacuum, according to the Natural Products Association (NPA). New Hampshire recently joined Virginia, Texas and Hawaii ...
Dietary Supplement Usage Up Dramatically During Pandemic, New Ipsos-CRN Survey Shows
The Council for Responsible Nutrition (CRN) has issued results of a COVID-19-focused consumer survey that discovered more than two in five (43 percent) of dietary supplement users have changed their supplement routines since the start of the pandemic. Among those who altered their regimens due to COVID-19, 91 percent report increasing their supplement intake which ...
NPA Proposes Streamlined Data Sharing at FDA
The Natural Products Association (NPA) outlined a streamlined process to facilitate data sharing within the agency in comments to the U.S. Food and Drug Administration (FDA). Specifically, NPA suggested sharing data from the Office of Dietary Supplement Programs on structure/function claim notifications, new dietary ingredient (NDI) notifications, current good manufacturing practice (cGMP) inspections and certificate ...
Comar to Expand East Coast Footprint
Comar (Voorhees, NJ), a premier health care plastic packaging, device and component supplier, has announced a major capacity expansion of its Buena plant operations by building a new offsite location in Vineland, NJ. The new 159,000-square-foot facility in Vineland is a 20-minute drive from the current facility, will be ISO 13485 certified, cGMP (current good ...
Don't Miss Out!
Industry Professionals
Stay Informed!
Stay informed about the latest health, nutrition, and wellness developments by signing up for a FREE subscription to Nutrition Industry Executive magazine and digital newsletter.
Once subscribed, you will receive industry insights, product trends, and important news directly to your doorstep and inbox.
Featured Listings:
